- Previous Close
7.55 - Open
7.53 - Bid 7.01 x 300
- Ask 7.09 x 300
- Day's Range
7.01 - 7.55 - 52 Week Range
7.01 - 40.57 - Volume
2,062,970 - Avg. Volume
1,781,260 - Market Cap (intraday)
635.91M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-3.03 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
12.05
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I IV clinical trial management, clinical pharmacology, and consulting services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
www.fortrea.comRecent News: FTRE
View MorePerformance Overview: FTRE
Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FTRE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FTRE
View MoreValuation Measures
Market Cap
635.91M
Enterprise Value
1.72B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.23
Price/Book (mrq)
0.47
Enterprise Value/Revenue
0.64
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-12.18%
Return on Assets (ttm)
-1.77%
Return on Equity (ttm)
-17.65%
Revenue (ttm)
2.7B
Net Income Avi to Common (ttm)
-271.5M
Diluted EPS (ttm)
-3.03
Balance Sheet and Cash Flow
Total Cash (mrq)
118.5M
Total Debt/Equity (mrq)
88.00%
Levered Free Cash Flow (ttm)
421.85M